Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 05/26 09:59:56 pm
9.49 USD   -2.37%
10:31p VANDA PHARMACEU : Announces FDA Approval of the Fanapt® Supplemental..
05/04 VANDA PHARMACEU : reports 1Q loss
05/04 VANDA PHARMACEU : Reports First Quarter 2016 Financial Results
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2016 05/23/2016 05/24/2016 05/25/2016 05/26/2016 Date
9.595(c) 9.56(c) 9.76(c) 9.72(c) 9.49(c) Last
637 451 764 115 520 866 618 391 743 770 Volume
+2.07% -0.36% +2.09% -0.41% -2.37% Change
More quotes
Financials ($)
Sales 2016 147 M
EBIT 2016 -38,1 M
Net income 2016 -30,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 167 M
EBIT 2017 -5,21 M
Net income 2017 -6,39 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 2,85x
Capi. / Sales 2017 2,51x
Capitalization 419 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its products portfolio includes HETLIOZ, Fanapt and Tradipitant, Trichostatin and AQW051.Vanda Pharmaceuticals was founded by... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
10:48p VANDA PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (fo..
10:31p VANDA PHARMACEUTICALS : Announces FDA Approval of the Fanapt® Supplemental New D..
05/12 VANDA PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-..
05/05 VANDA PHARMACEUTICALS : Assigned Patent
05/05 VANDA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
05/04 VANDA PHARMACEUTICALS : reports 1Q loss
05/04 VANDA PHARMACEUTICALS INC. : Results of Operations and Financial Condition, Fina..
05/04 VANDA PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
More news
Sector news : Bio Therapeutic Drugs
09:05p ALDER BIOPHARMACEUTICALS : Continues to Strengthen and Expand Leadership Team to..
03:35pDJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
02:46p REGENERON PHARMACEUTICALS : Selected by Society for Science & the Public as New ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/23 Key FDA decisions coming this week
05/21 Tracking John Paulson's Paulson & Company Portfolio - Q1 2016 Update
05/04 Vanda Pharmaceuticals (VNDA) Q1 2016 Results - Earnings Call Webcast
05/04 Vanda Pharmaceuticals beats by $0.07, beats on revenue
05/03 Notable earnings after Wednesday?s close
Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions